211 related articles for article (PubMed ID: 12072488)
1. Neutralizing anti-F glycoprotein and anti-substance P antibody treatment effectively reduces infection and inflammation associated with respiratory syncytial virus infection.
Haynes LM; Tonkin J; Anderson LJ; Tripp RA
J Virol; 2002 Jul; 76(14):6873-81. PubMed ID: 12072488
[TBL] [Abstract][Full Text] [Related]
2. Discovery of a Prefusion Respiratory Syncytial Virus F-Specific Monoclonal Antibody That Provides Greater
Zhao M; Zheng ZZ; Chen M; Modjarrad K; Zhang W; Zhan LT; Cao JL; Sun YP; McLellan JS; Graham BS; Xia NS
J Virol; 2017 Aug; 91(15):. PubMed ID: 28539438
[TBL] [Abstract][Full Text] [Related]
3. Immunoprophylaxis and immunotherapy of respiratory syncytial virus-infected mice with respiratory syncytial virus-specific immune serum.
Graham BS; Davis TH; Tang YW; Gruber WC
Pediatr Res; 1993 Aug; 34(2):167-72. PubMed ID: 8233720
[TBL] [Abstract][Full Text] [Related]
4. Effects of anti-g and anti-f antibodies on airway function after respiratory syncytial virus infection.
Han J; Takeda K; Wang M; Zeng W; Jia Y; Shiraishi Y; Okamoto M; Dakhama A; Gelfand EW
Am J Respir Cell Mol Biol; 2014 Jul; 51(1):143-54. PubMed ID: 24521403
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic treatment with a G glycoprotein monoclonal antibody reduces pulmonary inflammation in respiratory syncytial virus (RSV)-challenged naive and formalin-inactivated RSV-immunized BALB/c mice.
Radu GU; Caidi H; Miao C; Tripp RA; Anderson LJ; Haynes LM
J Virol; 2010 Sep; 84(18):9632-6. PubMed ID: 20592094
[TBL] [Abstract][Full Text] [Related]
6. A respiratory syncytial virus (RSV) anti-G protein F(ab')2 monoclonal antibody suppresses mucous production and breathing effort in RSV rA2-line19F-infected BALB/c mice.
Boyoglu-Barnum S; Gaston KA; Todd SO; Boyoglu C; Chirkova T; Barnum TR; Jorquera P; Haynes LM; Tripp RA; Moore ML; Anderson LJ
J Virol; 2013 Oct; 87(20):10955-67. PubMed ID: 23885067
[TBL] [Abstract][Full Text] [Related]
7. Respiratory syncytial virus infection and G and/or SH protein expression contribute to substance P, which mediates inflammation and enhanced pulmonary disease in BALB/c mice.
Tripp RA; Moore D; Winter J; Anderson LJ
J Virol; 2000 Feb; 74(4):1614-22. PubMed ID: 10644330
[TBL] [Abstract][Full Text] [Related]
8. Preparation and Evaluation of the Fully Humanized Monoclonal Antibody GD-mAb Against Respiratory Syncytial Virus.
Tian P; Wang Y; Liu H; Yang Y; Wu X; Wei H; Chen T
Front Cell Infect Microbiol; 2019; 9():275. PubMed ID: 31417879
[TBL] [Abstract][Full Text] [Related]
9.
van Erp EA; van Kasteren PB; Guichelaar T; Ahout IML; de Haan CAM; Luytjes W; Ferwerda G; Wicht O
J Virol; 2017 Nov; 91(21):. PubMed ID: 28794038
[TBL] [Abstract][Full Text] [Related]
10. Prophylaxis with a respiratory syncytial virus (RSV) anti-G protein monoclonal antibody shifts the adaptive immune response to RSV rA2-line19F infection from Th2 to Th1 in BALB/c mice.
Boyoglu-Barnum S; Chirkova T; Todd SO; Barnum TR; Gaston KA; Jorquera P; Haynes LM; Tripp RA; Moore ML; Anderson LJ
J Virol; 2014 Sep; 88(18):10569-83. PubMed ID: 24990999
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic monoclonal antibody treatment targeting respiratory syncytial virus (RSV) G protein mediates viral clearance and reduces the pathogenesis of RSV infection in BALB/c mice.
Haynes LM; Caidi H; Radu GU; Miao C; Harcourt JL; Tripp RA; Anderson LJ
J Infect Dis; 2009 Aug; 200(3):439-47. PubMed ID: 19545210
[TBL] [Abstract][Full Text] [Related]
12. Intranasal monoclonal IgA antibody to respiratory syncytial virus protects rhesus monkeys against upper and lower respiratory tract infection.
Weltzin R; Traina-Dorge V; Soike K; Zhang JY; Mack P; Soman G; Drabik G; Monath TP
J Infect Dis; 1996 Aug; 174(2):256-61. PubMed ID: 8699052
[TBL] [Abstract][Full Text] [Related]
13. Novel Respiratory Syncytial Virus-Like Particle Vaccine Composed of the Postfusion and Prefusion Conformations of the F Glycoprotein.
Cimica V; Boigard H; Bhatia B; Fallon JT; Alimova A; Gottlieb P; Galarza JM
Clin Vaccine Immunol; 2016 Jun; 23(6):451-9. PubMed ID: 27030590
[TBL] [Abstract][Full Text] [Related]
14. An anti-G protein monoclonal antibody treats RSV disease more effectively than an anti-F monoclonal antibody in BALB/c mice.
Boyoglu-Barnum S; Todd SO; Chirkova T; Barnum TR; Gaston KA; Haynes LM; Tripp RA; Moore ML; Anderson LJ
Virology; 2015 Sep; 483():117-25. PubMed ID: 25965801
[TBL] [Abstract][Full Text] [Related]
15. Recombinant human respiratory syncytial virus (RSV) monoclonal antibody Fab is effective therapeutically when introduced directly into the lungs of RSV-infected mice.
Crowe JE; Murphy BR; Chanock RM; Williamson RA; Barbas CF; Burton DR
Proc Natl Acad Sci U S A; 1994 Feb; 91(4):1386-90. PubMed ID: 8108420
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic administration of a complementarity-determining region derived from a neutralizing monoclonal antibody is effective against respiratory syncytial virus infection in BALB/c mice.
Bourgeois C; Bour JB; Aho LS; Pothier P
J Virol; 1998 Jan; 72(1):807-10. PubMed ID: 9420291
[TBL] [Abstract][Full Text] [Related]
17. Recombinant low-seroprevalent adenoviral vectors Ad26 and Ad35 expressing the respiratory syncytial virus (RSV) fusion protein induce protective immunity against RSV infection in cotton rats.
Widjojoatmodjo MN; Bogaert L; Meek B; Zahn R; Vellinga J; Custers J; Serroyen J; Radošević K; Schuitemaker H
Vaccine; 2015 Oct; 33(41):5406-5414. PubMed ID: 26319741
[TBL] [Abstract][Full Text] [Related]
18. Passive protection of gnotobiotic calves using monoclonal antibodies directed at different epitopes on the fusion protein of bovine respiratory syncytial virus.
Thomas LH; Cook RS; Wyld SG; Furze JM; Taylor G
J Infect Dis; 1998 Apr; 177(4):874-80. PubMed ID: 9534958
[TBL] [Abstract][Full Text] [Related]
19. Discovery and Characterization of Phage Display-Derived Human Monoclonal Antibodies against RSV F Glycoprotein.
Chen Z; Zhang L; Tang A; Callahan C; Pristatsky P; Swoyer R; Cejas P; Nahas D; Galli J; Cosmi S; DiStefano D; Hoang VM; Bett A; Casimiro D; Vora KA
PLoS One; 2016; 11(6):e0156798. PubMed ID: 27258388
[TBL] [Abstract][Full Text] [Related]
20. Development of bioluminescence imaging of respiratory syncytial virus (RSV) in virus-infected live mice and its use for evaluation of therapeutics and vaccines.
Fuentes S; Arenas D; Moore MM; Golding H; Khurana S
Vaccine; 2017 Jan; 35(4):694-702. PubMed ID: 27989627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
